Segment, Customer and Geographical Reporting (Tables)

9 Months Ended

Jun. 30, 2015

The Company’s segment information for the three months ended June 30, 2015 and 2014 is summarized below:

Results of Operations for the Three Months Ended June 30,
2015
	Contract
	Research			Optics			Instruments		Biomedical		Total
Revenue	$	4,626,000		$	5,613,000		$	-	$	-	$	10,239,000
Gross Profit		2,027,000			2,191,000			-		-		4,218,000
GM %		43.8	%		39.0	%		-		-		41.2	%
SG&A		1,934,000			1,565,000			-		236,000		3,735,000
Loss on sale of assets		-			(8,000)			-		-		(8,000)
Operating Income (Loss)		93,000			618,000			-		(236,000)		475,000

Depreciation and Amortization		74,000			223,000			-		15,000		312,000
Capital expenditures		-			270,000			-		21,000		291,000

Intangibles, Net		273,000			722,000			-		257,000		1,252,000
Goodwill		4,939,000			1,252,000			-		-		6,191,000
Total Assets	$	9,462,000		$	16,615,000		$	50,000	$	756,000	$	26,883,000

Results of Operations for the Three Months Ended June 30,
2014
	Contract Research			Optics			Instruments		Biomedical			Total
Revenue	$	5,461,000		$	5,172,000		$	-	$	8,000		$	10,641,000
Gross Profit		2,121,000			1,741,000			-		8,000			3,870,000
GM %		38.8	%		33.7	%		-		100.0	%		36.4	%
SG&A		2,057,000			1,516,000			(10,000)		181,000			3,744,000
Gain on sale of assets		-			-			30,000		-			30,000
Operating Income (Loss)		64,000			225,000			40,000		(173,000)			156,000

Depreciation and Amortization		70,000			190,000			-		15,000			275,000
Capital expenditures		-			1,937,000			-		-			1,937,000

Intangibles, Net		307,000			893,000			-		133,000			1,333,000
Goodwill		4,939,000			1,394,000			-		-			6,333,000
Total Assets	$	9,451,000		$	16,053,000		$	335,000	$	632,000		$	26,471,000

The Company’s segment information for the nine months ended June 30, 2015 and 2014 is summarized below:

Results of Operations for the Nine Months Ended June 30,
2015
	Contract
	Research			Optics			Instruments		Biomedical		Total
Revenue	$	13,964,000		$	15,781,000		$	-	$	-	$	29,745,000
Gross Profit		6,077,000			5,408,000			-		-		11,485,000
GM %		43.5	%		34.3	%		-		-		38.6	%
SG&A		5,712,000			5,150,000			-		739,000		11,601,000
Gain on sale of assets		-			178,000			-		-		178,000
Operating Income (Loss)		365,000			436,000			-		(739,000)		62,000

Depreciation and Amortization		222,000			631,000			-		45,000		898,000
Capital expenditures		4,000			666,000			-		77,000		747,000

Intangibles, Net		273,000			722,000			-		257,000		1,252,000
Goodwill		4,939,000			1,252,000			-		-		6,191,000
Total Assets	$	9,462,000		$	16,615,000		$	50,000	$	756,000	$	26,883,000

Results of Operations for the Nine Months Ended June 30,
2014
	Contract Research			Optics			Instruments			Biomedical			Total
Revenue	$	16,915,000		$	14,059,000		$	773,000		$	11,000		$	31,758,000
Gross Profit		7,093,000			5,175,000			318,000			11,000			12,597,000
GM %		41.9	%		36.8	%		41.1	%		100.0	%		39.7	%
SG&A		6,439,000			4,030,000			529,000			579,000			11,577,000
Gain on sale of assets		-			-			1,217,000			-			1,217,000
Operating Income (Loss)		654,000			1,145,000			1,006,000			(568,000)			2,237,000

Depreciation and Amortization		209,000			551,000			2,000			47,000			809,000
Capital expenditures		12,000			2,606,000			-			-			2,618,000

Intangibles, Net		307,000			893,000			-			133,000			1,333,000
Goodwill		4,939,000			1,394,000			-			-			6,333,000
Total Assets	$	9,451,000		$	16,053,000		$	335,000		$	632,000		$	26,471,000

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended June 30, 2015 and 2014 are as follows:

Revenue by geographic location in total and as a percentage of total revenue, for the nine months ended June 30, 2015 and 2014 are as follows: